Kane Realty, CMC Plan Raleigh Hotel

Add CPE to Google

The 250-room hotel is part of a larger mixed-use development.

Kane Realty Corp. and Raleigh-based CMC Hotels are planning an Autograph Collection hotel by Marriott for Kane’s North Hills Innovation District, a 33-acre mixed-use development in Raleigh, N.C.

The future hotel will be constructed at 500 Hardimont Road and include 250 rooms. The project will also include a street-level restaurant, a rooftop restaurant, a speakeasy and a swimming pool with private cabanas and outdoor terraces. The property will also offer meeting and event spaces, including a ballroom. Construction is scheduled to start in the third quarter of 2027.

The 33-acre NHID development is already partially delivered. At full buildout, the district is expected to include approximately 1,500 apartments and 60,000 square feet of retail space, along with office properties. Completed projects include Tower 5, a 17-story 342,000-square-foot office tower that came online in 2025

Work is underway on Tributary, the next residential component, while three other residential projects are expected to break ground in 2027. Planning has also begun for another office tower at NHID, which would become the district’s second trophy office building and the seventh office tower in North Hills overall. Plans include ground-level retail and a connection to an adjacent park.


READ ALSO: Live-Work-Play Development Enters Next Golden Age


In April, Couchbase Inc., an AI operational data platform company, signed a 20,000-square-foot lease at 4350 Lassiter, in the North Hills’ Main District. The tenant is occupying an entire floor at the building.

Major projects advance in the Research Triangle

Across the Research Triangle, major developments are progressing across multiple asset classes. In August, Genentech topped out its $2 billion, 700,000-square-foot manufacturing facility in Holly Springs, N.C. The project marks the company’s first East Coast facility, with operations expected to begin in 2029.

Separately, AbbVie is investing $1.4 billion over the next four years to build a 185-acre manufacturing campus in Durham, N.C., which is set to deliver in 2028. The project represents the biopharmaceutical company’s first project in North Carolina.